Vaccine composition

Details for Australian Patent Application No. 2005203302 (hide)

Owner GlaxoSmithKline Biologicals s.a.

Inventors Boutriau, Dominique; Poolman, Jan; Lemoine, Dominique; Desmons, Pierre Michel; Capiau, Carine

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005203302

Parent 2001281895

Filing date 27 July 2005

Wipo publication date 18 August 2005

International Classifications

A61K 039/00 Medicinal preparations containing antigens or antibodies

Event Publications

11 August 2005 Complete Application Filed

18 August 2005 Application Open to Public Inspection

  Published as AU-A-2005203302

23 February 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005203303-Quinazoline ditosylate salt compounds

2005203301-Compositions and methods for treating skin conditions